(Press-News.org) A relatively new class of insecticide that can be disseminated on something the size of a sheet of paper offers protection for up to a year against mosquitoes that spread malaria, as well as dengue, West Nile, yellow fever, and Zika, UC San Francisco researchers have found.
In a systematic review of more than 25 years of data on some 1.7 million mosquitoes, researchers concluded that this form of repellent — called a “spatial emanator” because it distributes chemicals through the air — can prevent more than 1 out of every 2 mosquito bites.
The analysis comes just as the World Health Organization (WHO) issued a new recommendation in August supporting the use of spatial emanators, the first new vector control product class available in more than 40 years.
Spatial emanators can be used day and night and do not require heating or electricity, making them easy to use in remote areas in Africa, South America, and Southeast Asia, where malaria is prevalent.
“We finally have a new way to protect against mosquito bites, especially one that fills in some of the gaps of our existing methods,” said Ingrid Chen, PhD, MS, an associate professor of epidemiology and biostatistics at UCSF and the first author of the paper. “It’s lightweight, affordable, and easy to use, so it can be used to help save lives in all parts of the world.”
The study was funded by the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health (NIH). It appears Aug. 26 in eBioMedicine, which is published by The Lancet. The NIH is not accepting applications for future research on this topic, which relies on foreign subawards to study the products in countries where people still die from mosquito-borne diseases.
Malaria’s devastating impact
Malaria killed 597,000 people in 2023, the vast majority of whom were children under 5 years old in sub-Saharan Africa. Malaria has not been endemic to the U.S. since the 1950s, although locally transmitted cases occasionally occur in places like Florida and Texas.
WHO aims to reduce malaria mortality rates by at least 90% from where they were in 2015 and eliminate malaria in at least 35 countries by 2030. But progress toward this goal has slowed in recent years, due to the COVID-19 pandemic, insufficient funding, and insecticide resistance.
More than 40 species of mosquitoes transmit malaria, and they all have different biting and resting habits. Some, like the Anopheles mosquito, which carries the malaria parasite, bite mostly at night. Others, like the Aedes mosquito, which carries viruses like dengue and Zika, bite during the day.
This makes it hard for one method to work against them all.
Insecticide-treated nets generally only protect people indoors and at night, and there are other limitations. Topical repellents are expensive and need to be regularly reapplied. Insecticide-treated coils create smoke and last only a few hours.
The new class of spatial repellent overcomes these coverage gaps. It uses chemicals that are similar to those in treated bed nets — which are considered safe — but in a more volatile form.
Effective against all types of mosquitoes
The researchers looked at years of research, analyzing each mosquito that has been collected and characterized, and put the data together into one big database.
They determined that these spatial repellents provide an average protectiveness of 56%, meaning they prevented more than half the bites that would have occurred without the device. The tool also protects against all types of mosquitoes that carry disease, although with varying levels of efficacy.
Three products, BiteBarrier, Mosquito Shield, and Guardian, are already being produced. BiteBarrier is the first to be sold in the U.S., and it works for up to 21 days. Mosquito Shield is effective for about 30 days, while Guardian can last up to one year.
The Aug. 13 WHO recommendation enables major donors to subsidize this intervention in malaria-endemic countries, specifically using Mosquito Shield and Guardian.
Authors: Additional UCSF co-authors include Isabel Elaine Allen, PhD, and Sarah L. Miller, MS. Nearly 50 researchers from 15 countries also contributed to this work including senior author Sarah J. Moore, who leads mosquito product testing research in the Vector Biology Unit of the Swiss Tropical and Public Health Institute at the Ifakara Health Institute in Tanzania.
Funding: This work was supported by a grant through the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) (K01AI156182). Moore, the senior author, received salary support through a program funded by the U.S. Agency for International Development (7200AA23CA000025).
About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at ucsf.edu, or see our Fact Sheet.
###
Follow UCSF
ucsf.edu | Facebook.com/ucsf | YouTube.com/ucsf
END
How a malaria-fighting breakthrough provides lasting protection
WHO has recommended the first new class of vector control products in more than 40 years.
2025-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Cognitive Behavioural therapy can alter brain structure and boost grey matter volume, study shows
2025-08-27
Psychotherapy leads to measurable changes in brain structure. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Münster have demonstrated this for the first time in a study in “Translational Psychiatry” by using cognitive behavioural therapy. The team analysed the brains of 30 patients suffering from acute depression. After therapy, most of them showed changes in areas responsible for processing emotions. The observed effects are similar to those already known from studies on medication.
Around ...
Largest ever study into cannabis use investigates risk of paranoia and poor mental health in the general population
2025-08-27
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in partnership with the University of Bath, has found that the reasons why a person chooses to use cannabis can increase their risk of developing paranoia.
The use and potency of cannabis is increasing worldwide, and dependence and cannabis-induced psychosis are also greatly increasing as a result, especially in North America. Two new research papers, both using data from Cannabis & Me - the largest survey of its kind - have identified key risk factors associated ...
Most US neurologists prescribing MS drugs have received pharma industry cash
2025-08-26
Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5 year analysis of Medicare database payments, published in the open access journal BMJ Open.
And those in receipt of these payments were more likely to prescribe that company’s drugs, especially if the sums involved were larger, sustained, and recent, the findings indicate.
Because of the lifelong nature of MS, effective therapies are usually continued indefinitely unless a patient’s clinical response changes, explain the researchers. And MS drug prescriptions are ...
A growing baby planet photographed for first time in a ring of darkness
2025-08-26
A team of astronomers has detected for the first time a growing planet outside our solar system, embedded in a cleared gap of a multi-ringed disk of dust and gas.
The team, led by University of Arizona astronomer Laird Close and Richelle van Capelleveen, an astronomy graduate student at Leiden Observatory in the Netherlands, discovered the unique exoplanet using the University of Arizona's MagAO-X extreme adaptive optics system at the Magellan Telescope in Chile, the U of A's Large Binocular Telescope in Arizona and the Very Large Telescope at the European Southern Observatory in Chile. ...
Brain’s immune cells key to wiring the adolescent brain
2025-08-26
Making a smoothie, going for an evening walk, or having empathy for a loved one are all examples of executive functions that are controlled by the brain’s frontal cortex. This area of the brain goes through profound change throughout adolescence, and it is during this time that abnormalities in maturing circuits can set the stage for neurodevelopmental disorders, such as schizophrenia and ADHD. Researchers at the Del Monte Institute for Neuroscience at the University of Rochester have discovered that microglia, the brain’s immune cells, ...
KAIST develops AI that automatically detects defects in smart factory manufacturing processes even when conditions change
2025-08-26
Recently, defect detection systems using artificial intelligence (AI) sensor data have been installed in smart factory manufacturing sites. However, when the manufacturing process changes due to machine replacement or variations in temperature, pressure, or speed, existing AI models fail to properly understand the new situation and their performance drops sharply. KAIST researchers have developed AI technology that can accurately detect defects even in such situations without retraining, achieving performance improvements ...
Research alert: Alcohol opens the floodgates for bad bacteria
2025-08-26
Alcohol-associated liver disease (ALD) is a major cause of liver transplantation and death worldwide, and its impact is only growing. In 2022, the annual cost of ALD in the United States was $31 billion. By 2040, this number could be as high as $66 billion. ALD has limited therapeutic options, so scientists are looking for new ways to target the molecular biology of ALD to help prevent its occurrence or reduce its severity.
Now, scientists at University of California San Diego School of Medicine have found that chronic alcohol use impairs the production of a key cellular signaling ...
American Gastroenterological Association, Latica partner to assess living guidelines using real-world evidence
2025-08-26
Palo Alto, CA and Bethesda, MD (Aug. 26, 2025) – American Gastroenterological Association (AGA) is proud to announce a new collaboration with, Latica, a leader in real-world clinical data and artificial intelligence-driven research solutions, to support a real-world evidence initiative: the IBD Living Guidelines Real-World Evidence Study. The study will be powered by Latica’s proprietary data platform and robust clinical datasets, in partnership with Latica’s GI Network, starting with data from Gastro Health and Allied Digestive Health, two of the largest and most respected community gastroenterology practices ...
University of Tennessee collaborates on NSF grants to improve outcomes through AI
2025-08-26
Faculty members from the Min H. Kao Department of Electrical Engineering and Computer Science at University of Tennessee are involved in two collaborative National Science Foundation grants that aim to address health disparities research and enhance the performance and productivity of AI science.
Tabitha Samuel, the interim director and operations group leader for UT’s National Institute for Computational Sciences (NICS), is the principal investigator for UT on both projects.
AI Advancement in Health ...
New technique at HonorHealth Research Institute uses ultrasound to activate drugs targeting pancreatic cancer
2025-08-26
SCOTTSDALE, Ariz. — Aug. 16, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is combining the power of targeted drugs and ultra-sound technology to shrink the tumors of patients whose cancer has not spread to other parts of the body but is too advanced to allow safe surgical removal.
Acoustic Cluster Therapy (ACT) uses tiny clusters of gas bubbles and oil droplets that make up PS101, which is combined with a modified version of FOLFIRINOX, an FDA-approved combination of four ...
LAST 30 PRESS RELEASES:
Tiny 3D printer reconstructs tissues during vocal cord surgery
New genetic marker found to predict severe gout drug reactions in US patients
Schizophrenia, bipolar, or major depressive disorder and postacute sequelae of COVID-19
Fruit flies offer new insights into how human Alzheimer’s Disease risk genes affect the brain
University of Phoenix College of Doctoral Studies releases white paper on mentoring programs to strengthen worker autonomy and competitive edge
International scientists issue State of the Climate Report, highlight mitigation strategies
“State of the climate” 2025: Earth’s vital signs worsen, science shows options for livable future
New nanomedicine wipes out leukemia in animal study
National TRAP Program targets ghostly issue with second round of coastal clean up funding
Six scientists receive AFAR grants for junior faculty
Climate report: Earth on dangerous path but rapid action can avert the worst outcomes
American Pediatric Society announces Bruce D. Gelb, MD, as recipient of its prestigious 2026 APS John Howland Award
Friendships can ease loneliness for dementia caregivers
Researchers pose five guiding questions to improve the use of artificial intelligence in physicians’ clinical decision-making
Global call to “Help the Kelp” with US $14 billion conservation target
Artificial tongue uses milk to determine heat level in spicy foods
IU Kelley Futurecast: AI and energy infrastructure may buoy US economy in 2026
The biggest threats to maintaining fat bike trails: climate change and volunteer burnout
AI models for drug design fail in physics
Practice pattern of aerosol drug therapy in acute respiratory distress syndrome patients: An aero-in-ICU study
GLIS model as a predictor of outcomes in older adults with heart failure
Molecules in motion: pioneering the era of supramolecular robotics
Faster and more reliable crystal structure prediction of organic molecules
Thankful at work: A two-week gratitude journal boosts employee engagement
Fibroblasts: Hidden drivers of heart failure progression
IOCB Prague unveils a fundamentally faster, more affordable way to produce quantum nanodiamonds
Artificial intelligence takes the lead in revolutionizing cancer research explored at NFCR’s 2025 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.
Switching memories on and off with epigenetics
This is your brain without sleep
3D DNA looping discovery in rice paves the way for higher yields with less fertilizer
[Press-News.org] How a malaria-fighting breakthrough provides lasting protectionWHO has recommended the first new class of vector control products in more than 40 years.